Hyperperfusion on magnetic resonance imaging in acute chemotherapy-related leukoencephalopathy

Journal of Child Neurology

Volumn 25, Issue 6, 2010, Pages 776-779

  El Hakam, Lisa Michael ^a   Ramocki, Melissa Beth ^a   Riviello, James John ^a   Illner, Anna ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Chemotherapy; Leukoencephalopathy; Magnetic resonance imaging; Magnetic resonance perfusion; Methotrexate

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE MACROGOL; CYTARABINE; METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; APHASIA; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; DYSARTHRIA; FACE DISORDER; HEMIPLEGIA; HUMAN; LEUKOENCEPHALOPATHY; MALE; MULTIPLE CYCLE TREATMENT; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD; SCINTIGRAPHY; SYMPTOM; WEAKNESS;

ACUTE DISEASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; CYTARABINE; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; POLYETHYLENE GLYCOLS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; STROKE; VINCRISTINE;

EID: 77952899401     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073809346349     Document Type: Article

References (14)

1. Baehring JM, Fulbright RK Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients. J Neurol Neurosurg Psychiatry. 2008 ; 79 (5). 535-539.
2. Mahoney DH Jr, Shuster JJ, Nitschke R., et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy-a Pediatric Oncology Group study. J Clin Oncol. 1998 ; 16 (5). 1712-1722.
3. Packer RJ, Zimmerman RA, Bilaniuk LT Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage. Cancer. 1986 ; 58 (3). 635-640.
4. Inaba H., Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol. 2008 ; 19 (1). 178-184.
5. Raghavendra S., Nair MD, Chemmanam T., Krishnamoorthy T., Radhakrishnan VV, Kuruvilla A. Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate. Eur J Neurol. 2007 ; 14 (3). 309-314.
6. Grisold W., Oberndorfer S., Struhal W. Stroke and cancer: a review. Acta Neurol Scand. 2009 ; 119 (1). 1-16.
7. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM Stroke in patients with cancer: incidence and etiology. Neurology. 2004 ; 62 (11). 2025-2030.
8. Haykin ME, Gorman M., van Hoff J., Fulbright RK, Baehring JM. Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity. J Neurooncol. 2006 ; 76 (2). 153-157.
9. Eichler AF, Batchelor TT, Henson JW Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate. Neuro Oncol. 2007 ; 9 (3). 373-377.
10. Drachtman RA, Cole PD, Golden CB, et al. Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity. Pediatr Hematol Oncol. 2002 ; 19 (5). 319-327.
11. Hsu WH, Chu SJ, Tsai WC, Tsao YT Acute myeloid leukemia presenting as one-and-a-half syndrome. Am J Emerg Med. 2008 ; 26 (4). 513e1-2.
12. Olivot JM, Mlynash M., Thijs VN, et al. Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke. 2008 ; 39 (8). 2257-2263.
13. Makiranta MJ, Lehtinen S., Jauhiainen JP, Oikarinen JT, Pyhtinen J., Tervonen O. MR perfusion, diffusion and BOLD imaging of methotrexate-exposed swine brain. J Magn Reson Imaging. 2002 ; 15 (5). 511-519.
14. Akiba T., Okeda R., Tajima T. Metabolites of 5-fluorouracil, alphafluoro-beta-alanine and fluoroacetic acid, directly injure myelinated fibers in tissue culture. Acta Neuropathol. 1996 ; 92 (1). 8-13.